Presentation on theme: "Dr Patricia Oakley, Director Practices made Perfect Ltd. Teaching and Research Fellow Organisational Psychology and HRM King’s College London Tel: 0845."— Presentation transcript:
Dr Patricia Oakley, Director Practices made Perfect Ltd. Teaching and Research Fellow Organisational Psychology and HRM King’s College London Tel: Fax: The NHS Reforms – a Policy Analyst’s View The Procurement and Distribution Interest Group Conference : 9 th June 2011
11e31449aso1 Focus on the Future – The Wheel Turns Again Proposed Streamlined Public Service Architecture* Independent Reconfiguration Panel Care Quality Commission Monitor- Market Regulator Workforce Regulators Pay Review Bodies Workforce – Human Resources Development Shared Service Agency Deanery Schools and HIECs. Assessment Centres. Leadership and organisational Development Consortia. Workforce – Strategic Planning and Investment Shared Service Agency Recruitment and Payroll Agencies. Workforce Planning and Information Consortium. Education and Training Commissioning Consortium. Local Authority Commissioning Agency: − Multi-agency service commissioning; − Public Health Programmes; − “residual” services commissioning. GP Commissioning Groups – Managed Agencies for majority of local people’s needs. GP-Patients Commissioning Partners: − Individual Choice; − Co-Payment Choice; − Means-Tested Services. Foundation Trusts and Academic Health Science Centres. Social Enterprises and Charities. Companies. Partnerships. £ £ Service Providers Network Dept. of [Public] Health Permanent Secretary and Chief Medical Officer. £ Independent NHS Board and its Regional Directorates Service Commissioning Agencies £ £ Chief Executive. Commissioning Director. ? Medical Director (inc. Workforce). ? Chief Officers (inc. workforce). ? Nursing Director (inc. workforce). ? Workforce Director. ? R&D Director. £ Controller. ? Subsume most of regional specialist commissioning groups’ work? ? Subsume the “Cancer Drugs Fund”? National Specialist Commissioning Group e.g. Transplant Programmes, Proton Beam Therapy and “Orphan” Drugs. *2 nd to be revised once White Paper has cleared Parliament and become the Health Act 2010.